9945:TWSERuentex Development Co., Ltd. Analysis
Data as of 2026-03-15 - not real-time
NT$27.90
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Ruentex Development (9945.TW) is trading at TWD 27.9, sitting below its 20‑day (28.75), 50‑day (29.27) and 200‑day (29.91) simple moving averages, indicating a short‑term bearish bias. The MACD histogram remains negative and the RSI at 39 suggests the stock is approaching oversold territory, while volume is on an increasing trend, providing a modest technical cushion near the identified support of 27.1. Fundamentally, the company boasts a striking 60.9 % revenue growth YoY and a PE of 8.1, far below the industry average of 29.1, positioning it as a clear undervaluation relative to peers. The DCF‑derived fair value of 29.87 implies a ~7 % upside from the current price, and a dividend yield of 3.94 % with a 32 % payout ratio underscores cash‑return attractiveness.
However, the firm carries a high debt load (≈ 62 billion TWD) and negative free cash flow, which tempers the upside narrative, especially in a sector sensitive to economic cycles. Volatility over the past 30 days sits near 22 % and beta is modest at 0.63, reflecting moderate market sensitivity but limited systemic risk. Given the blend of strong growth metrics, solid dividend sustainability, and a technical backdrop that may soon reverse, the stock presents a compelling case for investors with a medium‑to‑long horizon.
However, the firm carries a high debt load (≈ 62 billion TWD) and negative free cash flow, which tempers the upside narrative, especially in a sector sensitive to economic cycles. Volatility over the past 30 days sits near 22 % and beta is modest at 0.63, reflecting moderate market sensitivity but limited systemic risk. Given the blend of strong growth metrics, solid dividend sustainability, and a technical backdrop that may soon reverse, the stock presents a compelling case for investors with a medium‑to‑long horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below all major moving averages
- Negative MACD and RSI near oversold
- Increasing volume near support level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to industry PE
- Strong revenue growth (60.9%)
- Attractive dividend yield with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- DCF fair value suggests upside
- Sustainable dividend and solid cash flow generation
- Moderate beta and manageable market volatility
Key Metrics & Analysis
Financial Health
Revenue Growth60.90%
Profit Margin27.28%
P/E Ratio8.1
ROE11.92%
ROA2.22%
Debt/Equity56.56
P/B Ratio0.8
Op. Cash FlowNT$5.4B
Free Cash FlowNT$-5321264640
Industry P/E29.1
Technical Analysis
TrendBearish
RSI39.3
SupportNT$27.10
ResistanceNT$29.85
MA 20NT$28.75
MA 50NT$29.27
MA 200NT$29.91
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueNT$29.87
GradeUndervalued
TypeBlend
Dividend Yield3.94%
Risk Assessment
Beta0.63
Volatility22.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.